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Abstract
Background
HIV and Helicobacter pylori are common chronic infections in sub-Saharan Africa. Both
conditions can predispose to gastric hypochlorhydria that may be a risk factor for enteric
infections and reduced drug absorption. We have investigated to what extent HIV and H.
pylori infections are associated with hypochlorhydria in a Malawian cohort of patients under-
going endoscopy.
Methods
104 sequential symptomatic adults referred for gastroscopy at Queen Elizabeth Central
Hospital, Blantyre, Malawi, had blood taken for rapid HIV testing and fasting serum gastrin
analysis. Gastric fluid was aspirated for pH testing, and gastric biopsies were taken.
Results
After 9/104 HIV-infected patients who were already established on anti-retroviral therapy
were excluded, 17/95 (25.0%) were seropositive for untreated HIV, and 68/95 (71.6%)
patients were H. pylori positive by histology. Hypochlorhydria (fasting gastric pH>4.0) was
present in 55.8% (53/95) of patients. H. pylori infection was significantly associated with
hypochlorhydria (OR 2.91, [1.02-7.75], p=0.046). While single infection with HIV was not
significantly independently associated with hypochlorhydria. H. pylori and HIV co-infection
was more strongly associated with hypochlorhydria (OR 6.25, [1.33-29.43], p=0.020) than
either infection alone, suggesting an additive effect of co-infection. HIV infection was asso-
ciated with higher serum gastrin levels (91.3pM vs. 53.1pM, p=0.040), while H. pylori infec-
tion was not (63.1pM vs. 55.1pM, p=0.610). Irrespective of H. pylori and HIV status, most
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patients (>90%) exhibited pangastritis. Only three patients had histological evidence of gas-
tric atrophy, of which only one was HIV-infected.
Conclusion
H. pylori infection was associated with fasting hypochlorhydria, while HIV was not indepen-
dently associated. HIV and H. pylori co-infection, however, was more strongly associated
with hypochlorhydria than H. pylori infection alone. The mechanism of this apparent additive
effect between HIV and H. pylori remains unclear, but appears to be related to chronic pan-
gastritis rather than gastric atrophy, and associated with hypergastrinaemia in HIV-infected
individuals.
Introduction
Helicobacter pylori is a gram-negative, spiral bacterium that colonises the gastric mucosa. It is
typically acquired in childhood and persists throughout life in at least 50% of the world's popu-
lation [1]. Since its discovery by Marshall and Warren in 1983, [2] overwhelming evidence has
confirmed thatH. pylori induces inflammation of the gastric mucosa through humoral and cel-
lular immune mechanisms. Over time this leads to the development of chronic active gastritis,
and in some cases peptic ulceration and gastric adenocarcinoma [1,3,4]. The host immune sys-
tem is usually ineffective in eradicating the infection, yet the host inflammatory response
causes a functional disruption to acid homeostasis, especially when the corpus mucosa is
involved [2,5]. An important consequence of chronic H. pylori gastritis in some individuals is
therefore low gastric acid output and hypochlorhydria [6]. Eradication of H. pylorimay reverse
this hypochlorhydria if atrophic gastritis has not already become established [1,7].
The association between H. pylori infection and hypochlorhydria is important because
hypochlorhydria has been associated with increased susceptibility to enteric pathogens [2,8,9]
and reduced drug absorption [1,3,4,10]. Hypochlorhydria has also been found to increase with
age and to be commoner among males [2,5,11,12].
Human immunodeficiency virus (HIV) infection leads to a progressive loss of CD4+ T cells
[6,13]. This is seen especially in the mucosa of the gastrointestinal tract, where most CD4+ T
cells reside [14]. HIV infection is also associated with marked chronic inflammation of the gas-
tric mucosa [15,16] and several studies have demonstrated that it is associated with low acid
secretion and elevated fasting gastric pH [17–20]. One American study found that 93% (27/29)
of HIV positive patients had a raised gastric pH, with a mean pH of 5.9 compared to 2.9
(p<0.05) in HIV negative subjects [18]. The mechanism for hypochlorhydria remains
unknown, but a number of different hypotheses have been suggested. These include an autoim-
mune phenomenon (as high rates of anti-parietal antibodies are found in HIV patients) [18],
that chronic infection and/or inflammation have a general inhibitory effect on acid secretion
[21] or that the effect is due to an interaction withH. pylori.
At present the role of H. pylori infection in the gastrointestinal mucosa of HIV positive
patients has not been well defined [22]. What is clear is that HIV infected subjects with gastric
hypoacidity have significant drug malabsorption [23], and that this can sometimes be corrected
by eradication ofH. pylori [24].
One study found that over 90% of patients with AIDS also had histological chronic active
gastritis. However this did not appear to be explained by dual infection, asH. pylori was present
in only a minority of AIDS patients with chronic active gastritis in a Western setting. Chronic
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gastritis appeared as flattening of the surface epithelium and foveolar and shorter gastric pit
length on histology. There was also a reduction in the number of lymphocytes and plasma cells
in the lamina propria of HIV positive patients [16].
Gastrin is a peptide hormone that stimulates gastric acid (HCl) secretion by gastric parietal
cells. Its release by G-cells in the gastric antrum is stimulated by the presence of food in the gas-
tric lumen. Gastrin release is regulated by feedback inhibition via somatostatin from adjacent
D-cells in the presence of a low gastric pH [25]. High fasting circulating concentrations of gas-
trin are often found in patients with chronic gastritis (usually secondary toH. pylori infection
or pernicious anaemia) [26]. Chronic atrophic gastritis also in particular leads to the loss of
acid secreting parietal cells, hypochlorhydria and hypergastrinaemia. H. pylori infection itself
can also cause relatively mild hypergastrinaemia [27]. Several studies have reported higher
serum gastrin concentrations among HIV positive patients [20,28] while one study reported
that HIV status had no effect on serum gastrin levels [21].
We aimed to study the prevalence of hypochlorhydria (fasting pH>4) in symptomatic
patients referred for gastroscopy in Malawi, and to investigate to what extent this was associ-
ated withH. pylori and/or HIV infections. In particular we aimed to identify whether HIV
infection alone or as a co-infection with H. pylori was implicated in causing hypochlorhydria,
and to understand the mechanism by studying histological changes and gastrin levels.
Methods
We undertook a prospective descriptive study at the Queen Elizabeth Central Hospital, Blan-
tyre, Malawi over 5 months. We recruited sequential symptomatic adults referred from the
out-patient department for gastroscopy. We excluded patients under 18 years and those with
evidence of an acute upper gastrointestinal bleed, a history of varices resulting from portal
hypertension, or symptoms of dysphagia (given the high prevalence of oesophageal carcinoma
in this setting). Patients with HIV who were established on antiretroviral therapy (ART) were
recruited as an exploratory group, but were subsequently excluded from the main analysis per
protocol. Ethical approval for the study was given by the University of Malawi College of Medi-
cine Research and Ethics Committee (COMREC reference P.08/10/969), and all participants
gave written informed consent. A medical history was taken, including basic sociodemographic
details, smoking, alcohol and medication history and the ‘Shortened Leeds Dyspepsia Ques-
tionnaire’ was completed [29]. A 10ml fasting blood sample was taken for Rapid HIV testing
(Uni-gold [Trinity Biotech Plc, Wicklow, Ireland] and Determine [Alere Ltd, Stockport, UK].
These two tests were required to be concordant to confirm HIV infection. Serum was stored at
-80°C for later analysis of serum gastrin concentration.
All patients had a gastroscopy (after fasting for at least six hours), during which gastric fluid
was aspirated using a 20ml syringe through the endoscope channel, after the channel had been
emptied and dried by flushing with air. Fluid was tested using pH paper (Hydrion, Micro Essen-
tial Laboratory, USA). Gastric fluid pH>4 was defined as hypochlorhydria. Two biopsies were
taken from the gastric antrum (within 1 inch of the pylorus) and two from the gastric body
(greater curve, proximal third), for histology. All endoscopists had been trained and monitored
using reproducible direct observation endoscopy skills training tools, as part of an international
training programme, and were trained in upper gastrointestinal lesion recognition [30].
Histological analysis was performed by a consultant gastrointestinal histopathologist (TA)
who determined theH. pylori infection status and extent of any inflammatory and atrophic
gastritis, using the modified Sydney classification [31]. Gastrin analysis was performed by
radioimmunoassay using antibody L2, which reacts with G17 and G34, but not progastrin or
gly-gastrins as previously described [32].
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SPSS v19 (SPSS Inc, Chicago, IL) was used for statistical analyses. Summary statistics were
calculated and then contingency tables were used to investigate univariate associations, signifi-
cance being assessed using the standard chi-squared test. Logistic regression was then used to
investigate individual and combinatorial factors, using a stepwise approach. Statistical signifi-
cance was defined at 5% (p = 0.05).
Results
Patient characteristics and clinical history
104 patients were initially recruited but nine were subsequently excluded from further analysis,
per protocol, because they were HIV positive and already established on ARV medication. This
was because we primarily aimed to study the effect of H. pylori and untreated HIV infection on
fasting gastric acidity. The 9 patients on ARVmedication were analysed separately, as an
exploratory group.
The remaining 95 patients had a mean age of 33 years (sd 13.2), ranging from 18–78 years,
and 55 (57.9%) patients were female. There were 6 (6.3%) current smokers, of whom 4 were
male, and 14 (14.7%) patients regularly consumed alcohol of whom 9 were male. Overall, 68
(71.6%) patients were H. pylori positive and 17 (17.9%) were HIV positive and had not been
established on antiretroviral medication (ARV). All HIV rapid tests were concordant by both
methods.
Most patients were referred to gastroscopy after empirical outpatient treatment with combi-
nations of anti-secretory medication and antibiotics for dyspeptic or reflux symptoms, in an
attempt to eradicate presumed H. pylori infection.
Prior antibiotic usage was the norm, with 89 (93.7%) patients having taken at least one
course within the last year. The majority of patients received amoxicillin with a minority hav-
ing taken additional courses of metronidazole or ciprofloxacin. None of the prescriptions rep-
resented an accepted H. pylori eradication regimen [33]. Due to the time between the
outpatient appointment and gastroscopy, only 3 (3.2%) patients had taken antibiotics during
the two weeks prior to enrolment.
Anti-secretory medications had also commonly been used in the year prior to gastroscopy.
93 (97.8%) patients had received some form of treatment; omeprazole (n = 69), magnesium tri-
silicate (n = 22) or cimetidine (n = 2). As most prescriptions were only for a few weeks, only 5
(5.2%) patients had taken such treatment in the two weeks prior to gastroscopy.
The indication for gastroscopy
The commonest indication for gastroscopy was epigastric pain, which accounted for 87
(91.2%) referrals. Two patients were investigated for anaemia, two for previous haematemesis,
two for odynophagia, one for reflux symptoms and one to confirm peptic ulcer healing.
Patients’ symptoms were interrogated using the ‘Leeds Dyspepsia Questionnaire’. The com-
monest symptoms were reflux related (heartburn/regurgitation), which accounted for 46
(48.4%) patients. Of the remaining patients, ulcer-like (indigestion) symptoms were described
by 31 (32.6%), dysmotility-like (nausea) symptoms by 4 (4.2%) and 14 (14.7%) patients could
not identify a predominant symptom.
Gastroscopy findings
The commonest endoscopic findings in the stomach were erythematous (33.7%) and atrophic
(31.6%) gastritis. Normal gastric mucosa was seen in 33.7% of patients. Significant pathological
findings included two cases of oesophageal varices, one gastric ulcer and one gastric cancer,
Hypochlorhydria Associated with H. pylori and HIV Co-Infection
PLOS ONE | DOI:10.1371/journal.pone.0132043 August 5, 2015 4 / 13
Table 1. Endoscopic appearances of gastritis were seen in 63.2% (43/68) of H. pylori infected
patients and 64.7% (11/17) of HIV infected patients.
Patient characteristics and fasting gastric pH
In the HIV positive group, 76.5% (13/17) were also H. pylori positive (Table 2), which was not
significantly higher than 70.5% (55/78) in the HIV negative group, p = 0.622. The mean gastric
fluid pH overall was 4.7 (sd 2.4) and 55.8% (53/95) of patients were hypochlorhydric (defined
as a fasting gastric pH>4). Table 3 shows the mean pH readings by age (< or> = 40 years),
gender andH. pylori and HIV infection status.
Following univariate and multivariate analysis (Table 4),H. pylori infection was the only
variable that was significantly and independently associated with hypochlorhydria (OR 3.2
(1.1–9) p = 0.029), with 63.2% of H. pylori positive individuals being hypochlorhydric, com-
pared to 37.0% ofH. pylori negative individuals. There was also a non-significant trend
(p = 0.061) towards higher pH readings inH. pylori infected patients (Table 3). HIV infection
was not independently associated with hypochlorhydria (Table 4) or with high gastric fluid pH
(Table 3).
Effect of single infection or co-infection with H. pylori and HIV on
hypochlorhydria
There were 13 patients who had dual H. pylori and HIV infection and this group had a higher
proportion of hypochlorhydric patients (76.9%) than the groups with a single infection (H.
pylori 60.0%, HIV 50.0%) or no infection (34.8%) (Table 5).
In a binary logistic regression analysis, infection with H. pylori alone was associated with a
significantly increased OR for hypochlorhydria (OR 2.81 (1.02–7.75), p = 0.046) compared to
uninfected individuals, (Table 5). However, the highest and most significant risk for hypo-
chlorhydria was seen in patients who were co-infected with H. pylori and HIV, OR = 6.25
(1.33–29.43) (p = 0.020) (Table 6). The mean gastric pH for uninfected patients was 3.8 (CI:
2.0), for patients only infected withH. pylori it was 4.9 (CI: 2.5) and for patients only infected
Table 1. Findings at gastroscopy; the examination was entirely normal in 27 (26%) patients.
Gastroscopy ﬁndings No. (%)
Oesophagus
Normal 78 (81.7)
Candida 6 (6.7)
Oesophagitis 6 (6.7)
Hiatus hernia 3 (2.9)
Varices 2 (1.9)
Stomach
Normal 31 (32.6)
Erythematous gastritis 32 (33.7)
Atrophic gastritis 30 (31.6)
Gastric ulcer 1 (1.1)
Gastric cancer 1 (1.1)
Duodenum
Normal 84 (88.4)
Duodenitis 6 (6.3)
Not entered 5 (5.3)
doi:10.1371/journal.pone.0132043.t001
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with HIV it was 5.0 (CI: 2.9). For patients co-infected with HIV and H pylori it was 5.8 (CI:
2.4) (Fig 1), but there were no statistically significant differences between these groups.
In order to understand the possible mechanisms by which HIV and H. pylorimight act
together in an additive manner to cause hypochlorhydria, we evaluated gastric histology and
compared fasting serum gastrin concentrations.
Gastric Histopathology
Biopsies from the gastric antrum and body allowed gastritis to be described as antral predomi-
nant (Type B), corpus predominant (Type A) or pangastritis (Type AB). The degree of inflam-
mation, whether minimal (superficial) or full thickness and the type, whether chronic
(mononuclear infiltrate) or chronic active (mononuclear infiltrate with neutrophils) was also
recorded (Table 7). All biopsies were also assessed for evidence of gastric atrophy, intestinal
metaplasia and the presence ofH. pylori organisms.
Pangastritis was a near-universal finding in our patient cohort. Overall 99.0% (n = 94) of
gastric body biopsies and 93.7% (n = 89) of antral biopsies showed some evidence of chronic
inflammation. Over 90% ofH. pylori or HIV infected patients had evidence of chronic inflam-
mation, whether minimal or full thickness. Even in theH. pylori-negative and HIV negative
group, 82.6% (19/23) of patients showed some evidence of chronic stomach inflammation.
We found that chronic active pangastritis was absent from all mono HIV infected patients
(0/4), whereas over half of mono H. pylori infected patients had active inflammation. Secondly,
inH. pylori patients, active inflammation was more commonly seen in the antrum rather than
body (51% vs. 35%). Patients with dual H. pylori and HIV infection also showed a mixture of
chronic and chronic active inflammation in both the antrum and body. Interestingly, none of
the 4 patients infected only with HIV had evidence of active inflammation at either the antral
or body sites (Table 7).
Table 2. The number of patients who were infected with HIV orH. pylori.
HIV positive HIV negative Total
H. pylori infected 13 55 68
H. pylori uninfected 4 23 27
Total 17 78 95
doi:10.1371/journal.pone.0132043.t002
Table 3. Mean gastric pH values by age, gender,H. pylori and HIV status.
Variable pH, mean (sd) p value
Age group (years)
<40 (n = 77) 4.7 (2.4) 0.769
40 and over (n = 18) 4.9 (2.5)
Gender
Male (n = 40) 4.3 (2.5) 0.107
Female (n = 55) 5.1 (2.3)
H. pylori
Negative (n = 27) 4.0 (2.2) 0.061
Positive (n = 68) 5.0 (2.5)
HIV
Negative (n = 78) 4.6 (2.4) 0.117
Positive (n = 17) 5.6 (2.5)
doi:10.1371/journal.pone.0132043.t003
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There were three cases of intestinal metaplasia and a further three cases of gastric atrophy.
In only one of the cases of gastric atrophy was the patient HIV positive. The mean age of the
three patients who had gastric atrophy was 52 years, which was older than the mean study age
(34 years). Gastric atrophy appeared to be associated withH. pylori infection, which was found
in all three patients, whose endoscopic findings showed one gastric ulcer, one case of erythema-
tous gastritis and one normal study.
Gastric pH and fasting serum gastrin concentrations
The mean fasting serum gastrin concentration was 61pM (sd 69.1) with a range between
9–540pM. As anticipated, patients with hypochlorhydria had significantly higher serum gastrin
concentrations (77 vs. 41, p = 0.028). The mean fasting serum gastrin concentration for
patients withH. pylori infection (63.1pM) was not significantly different from that inH. pylori
negative patients (55.1pM, p = 0.610). However in patients with HIV infection, serum gastrin
concentrations were significantly higher than in HIV-uninfected individuals (91.3 vs. 53.1,
p = 0.040). Mean serum gastrin concentration in co-infected individuals was even higher at
105pM (sd 141). While the mean gastrin level was highest in this co-infected group (H.pylori
+ve HIV +ve), there were no significant differences seen between the uninfected, singly-
infected and co-infected groups (Fig 2).
Table 4. Univariate and binary logistic regression by factors potentially associated with hypochlorhydria.
Variable Hypochlorhydria/Total (%) Unadjusted (univariate) Adjusted (multivariate)
OR CI p value OR CI p value
Age group (years)
<40 42/77 (54.5) 1 - - 1 - -
40 and over 11/18 (61.1) 1.31 0.46–3.73 0.614 1.01 0.32–3.16 0.989
Gender
Male 18/39 (46.2) 1 - - 1 - -
Female 35/56 (62.5) 1.94 0.85–4.46 0.116 1.72 0.69–4.26 0.242
H. pylori
Negative 10/27 (37.0) 1 - - 1 - -
Positive 43/68 (63.2) 2.92 1.16–7.36 0.023 3.19 1.13–9.03 0.029
HIV
Negative 41/78 (52.6) 1 - - 1 - -
Positive 12/17 (70.6) 2.08 0.67–6.54 0.208 1.89 0.56–6.32 0.304
doi:10.1371/journal.pone.0132043.t004
Table 5. Age, gender and hypochlorhydria in subjects singly infected or co-infected withH. pylori or
HIV.
HP, HIV combination Age group (years), n (%) Gender, n (%) Hypochlorhydria, n
(%)
<40 40 and over Male Female Yes No
HP–ve & HIV–ve 20 (87.0) 3 (13.0) 15 (56.5) 10 (43.5) 8 (34.8) 15 (65.2)
HP+ve & HIV–ve 41 (74.5) 14 (25.5) 30 (54.5) 25 (45.5) 33 (60.0) 22 (40.0)
HP–ve & HIV+ve 4 (100) 0 4 (100) 0 2 (50.0) 2 (50.0)
HP+ve & HIV+ve 12 (92.3) 1 (7.7) 9 (69.2) 4 (30.8) 10 (76.9) 3 (23.1)
doi:10.1371/journal.pone.0132043.t005
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Exploratory description of HIV-infected patients on ART
Of the nine HIV positive patients on ARVs, 5 were H. pylori co-infected. These 9 had a mean
gastric fluid pH of 3.1 and fasting serum gastrin concentration of 55pM, values that were
almost identical to HIV negative patients.
Discussion
We have shown that in a population of dyspeptic Malawian adults, H. pylori infection was a
significant risk factor for hypochlorhydria. Furthermore, while infection with HIV alone was
not associated with hypochlorhydria, it appeared to have an additive effect withH. pylori infec-
tion, to increase the likelihood that a patient would be hypochlorhydric. These findings are
important because hypochlorhydria is associated with an increased risk of enteric infection and
impaired drug absorption, both of which are important factors in maintaining the health of
HIV infected patients [34]. Our findings offer an insight into a poorly understood and poten-
tially reversible problem.
Table 6. Binary logistic regression analysis investigating the impact of single infection or co-infection withH. pylori (HP) and HIV on the odds of
having hypochlorhydria.
Variable Hypochlorhydria/Total (%) Unadjusted (univariate)
OR CI p value
HP/HIV status
HP–ve & HIV–ve 8/23 (34.8) 1 - -
HP+ve & HIV–ve 33 /55 (60.0) 2.81 1.02–7.75 0.046
HP–ve & HIV+ve 2 /4 (50.0) 1.89 0.22–15.93 0.565
HP+ve & HIV+ve 10 /13 (76.9) 6.25 1.33–29.43 0.020
doi:10.1371/journal.pone.0132043.t006
Fig 1. The scatterplot displays the absolute pH values for the four groups in relation to H.pylori and
HIV infection status.
doi:10.1371/journal.pone.0132043.g001
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Chronic infection withH. pylori is well known to cause hypochlorhydria, through inflam-
matory interruption of acid production. HIV infection has also previously been shown to cause
hypochlorhydria and elevated serum gastrin concentrations, but the findings of studies have
been inconsistent, and the mechanism responsible for these effects is unknown [35]. We found
no statistically significant independent association of HIV, per se, with either pH or hypochlor-
hydria. We did however observe an additive effect in patients coinfected with HIV andH.
pylori causing increased hypochlorhydria, and significantly increased fasting serum gastrin
concentrations in HIV positive patients.
While most HIV infected patients were also infected withH. pylori (76.9%), the prevalence
ofH. pylori infection was not significantly higher than in the HIV negative group (70.5%). This
Table 7. Histological assessment of antral and corpus (body) biopsies from all subjects.
Antral Body
Normal Minimal Chronic
Inﬂammation
Chronic
Inﬂammation
Chronic Active
Inﬂammation
Normal Minimal Chronic
Inﬂammation
Chronic
Inﬂammation
Chronic Active
Inﬂammation
HP-ve,
HIV-ve
(n = 23)
4 (17.4) 10 (43.6) 6 (26.1) 3 (13.0) 1 (4.3) 11 (47.8) 10 (43.6) 1 (4.3)
HP+ve,
HIV-ve
(n = 55)
1 (1.8) 6 (10.9) 20 (36.4) 28 (50.9) 0 10 (18.2) 26 (47.3) 19 (34.5)
HP-ve, HIV
+ve (n = 4)
0 0 4 (100) 0 0 0 4 (100) 0
HP+ve, HIV
+ve
(n = 13)
1 (7.7) 1 (7.7) 4 (30.8) 7 (53.8) 0 1 (7.7) 4 (30.8) 8 (61.5)
doi:10.1371/journal.pone.0132043.t007
Fig 2. The scatterplot displays the serum gastrin (pM) levels for the four groups in relation toH.pylori
and HIV infection status.
doi:10.1371/journal.pone.0132043.g002
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is in line with other studies [36–38], some of which have actually found lower rates of H. pylori
infection in patients with progressive HIV infection and low CD4 counts [39,40].
Previous treatment for H. pylori infection is a potential confounder in this study. We found
that, because of constrained resources in Malawi, prior attempts at eradication therapy for H.
pylori were largely empirical, and never involved a recognized or effective regime, in keeping
with our previous findings [41]. Only 5% of patients were on antibiotics or acid suppression
during the fortnight prior to the study, and previous or current eradication therapy is therefore
unlikely to have directly affected our findings.
In order to understand potential mechanisms for this synergy, we evaluated histological
samples for H. pylori and HIV positive patients. Histological analysis of biopsies from both the
antrum and body demonstrated that chronic pangastritis (Type AB) was the norm in this
patient cohort, affecting 90% of patients irrespective of infection status. Given the ubiquitous
finding of chronic inflammation across all groups, it was not possible to demonstrate a clear
association between histological findings and other patient variables. However chronic active
inflammation, indicating the presence of neutrophils, did allow us to describe apparent differ-
ences between groups by infection profile. Chronic active pangastritis is a classical finding in
H. pylori infection; we found it was not present in mono HIV infected patients but was seen at
both sites in those who were mono infected withH. pylori, and was also seen at both sites in
co-infected. Interestingly, a Brazilian study found that antral chronic active gastritis was associ-
ated with both HIV andH. pylori infection, but that in the body of the stomach, chronic active
gastritis was seen in HIV-infected patients, independently of H. pylori infection [40].
We also described differences in the distribution of inflammation in the stomach. H. pylori
infection alone was more likely to lead to antral gastritis (which might not be expected to cause
a significant increase in serum gastrin concentrations), while pangastritis (more likely to cause
increased serum gastrin concentrations) was associated with co-infection with HIV.
We were able to establish that gastric atrophy was not the cause of hypochlorhydria in the
majority of our patients. There were only three case of gastric atrophy in our cohort and only
one of these cases was also HIV positive. This finding is consistent with the study of Kelly et al.
that was performed in a similar geographical setting [35], although their study did not report
onH. pylori infection. This is important because when atrophy has not become established,
then H. pylori eradication may reverse the hypochlorhydria.
Our study’s finding of a high prevalence of chronic inflammation, but a low prevalence of
gastric atrophy has also been shown in other studies from African populations [42]. Therefore,
the most likely reason for the rise in gastric pH with dual H. pylori and HIV infection is that
HIV infection results in greater chronic pangastric inflammation and resultant reduced gastric
acid secretion, as evidenced by the significantly higher serum concentrations of gastrin in HIV
infected patients.
Hypochlorhydria increases the risk of acquiring enteric infections and reduces drug absorp-
tion (for example anti-retroviral therapy and antibiotics). Our small, exploratory group of indi-
viduals established on ART showed a lower gastric pH, suggesting that ART treatment might
reverse the apparent synergistic effect of HIV and ameliorate hypochlorhydria. We can also
speculate that eradication ofH. pylori would reduce hypochlorhydria, even in the presence of
HIV. Either of these strategies might reduce the incidence of enteric infections and improve
absorption of medications. Longer-term follow up cohort studies would be required to evaluate
these possibilities.
Interestingly one small study has shown that eradication ofH. pylori also facilitates immune
reconstitution in HIV-1-infected immunological non-responders [43]. Similarly, Shelton et al
showed in a small study that eradication ofH. pylori in hypochlorhydric HIV patients
increased delavirdine absorption [24]. However eradication regimes would need to be more
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effective in our setting, as around 90% of our patients had already received empirical attempts
atH. pylori eradication, using unproven eradication regimes, prior to their gastroscopy, yet H.
pylori infection rates were still very high at 70% [41].
Weaknesses of this study include the inclusion of only symptomatic (mainly dyspeptic)
patients and the lack of assessment of HIV disease stage. Due to the relatively small size of the
study, there were power limitations. A larger study may have been able, for example, to detect a
clinically significant difference in the prevalence of H. pylori infection between HIV positive
and HIV negative individuals. The small number of co-infections also limited our ability to
explore the relationship statistically, and larger study might be able to add statistical resolution
to these findings. Most patients had been prescribed apparently ineffective attempts atH. pylori
eradication, but it remains possible that some of the subjects who were classified as H. pylori
negative in this study may have previously been infected but successfully treated. It could be
argued, that we should have excluded the three patients who received antibiotics and five
patients who took anti-secretory medications in the two weeks before the gastroscopy. In addi-
tion, assessing pH using a single fasting gastric fluid sample is not as sensitive in detecting
hypochlorhydria by measuring acid secretion. However the latter was not practicable in the
Malawian setting.
In conclusion, mono infection with H. pylori but not HIV was associated with hypochlorhy-
dria. This risk for hypochlorhydria was strongest, however, in patients with dualH. pylori and
HIV infection. Co-infected patients also demonstrated the highest mean gastric fluid pH, sug-
gesting an additive effect between the two infections to increase hypochlorhydria. The mecha-
nism of HIV-related induced hypochlorhydria in this setting remains unclear, but appears to
be associated with a chronic pangastritis as evidenced by the histology, and resulting high fast-
ing serum gastrin concentrations, and does not appear to be caused by gastric atrophy. This
suggests that the finding is reversible, and merits larger studies to confirm this finding, and fur-
ther studies of its impact and treatment.
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